Related Experiment Video
Updated: Oct 12, 2025
06:38
A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
13.8K
Supportive therapy and complementary medicine in renal cell carcinoma
M Johannsen1, C Stoll2, M Raida3
1Urology Practice Johannsen & Laux, Berlin and d-uo (Deutsche Uro-Onkologen), Berlin, Germany.
World Journal of Urology
|November 25, 2021
Summary
This guideline provides recommendations for supportive and complementary therapies in advanced renal cell carcinoma (RCC) patients. It emphasizes individualized palliative care and notes limited evidence for complementary medicine in RCC treatment.
Area of Science:
- Oncology
- Evidence-Based Medicine
- Palliative Care
Background:
- Advanced or metastatic renal cell carcinoma (RCC) requires comprehensive management beyond primary tumor treatment.
- Supportive and palliative care are crucial components of managing complex patient needs in advanced cancer.
Purpose of the Study:
- To offer guidance on supportive therapy and complementary medicine for advanced or metastatic renal cell carcinoma (RCC) patients.
- To align with the German interdisciplinary S3-guideline for RCC diagnosis, treatment, and follow-up.
Main Methods:
- Development of national clinical practice guidelines (S3-guidelines) adhering to the highest methodological quality.
- Formulation of evidence-based recommendations and statements based on available scientific evidence.
Main Results:
- Outlines the management of tumor-related symptoms, including pain and treatment side effects.
- Addresses palliative care and end-of-life care considerations for renal cell carcinoma patients.
Conclusions:
- Patients with advanced or metastatic RCC should receive individualized supportive and palliative care.
- Evidence supporting the use of complementary medicine in RCC treatment is currently very limited.
Related Concept Videos
01:28Chronic Kidney Disease III: Interprofessional Care
106
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
106
01:16Kidney Transplant III: Nursing Management
100
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
100
01:27Tumor Immunotherapy
725
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
725
02:57Targeted Cancer Therapies
7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.9K
02:49Cancer Therapies
8.1K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.1K
02:50Combination Therapies and Personalized Medicine
5.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.2K